Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES 简体中文 中文 हिन्दी HI
Sign Up
Log in
Fennec Pharmaceuticals Inc banner
F

Fennec Pharmaceuticals Inc
TSX:FRX

Watchlist Manager
Fennec Pharmaceuticals Inc
TSX:FRX
Watchlist
Price: 14.78 CAD Market Closed
Market Cap: CA$403.8m
Write Note Create Alert

Intrinsic Value

Is FRX undervalued or overvalued?

See the intrinsic value estimate for Fennec Pharmaceuticals Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

FRX Intrinsic Value
LOCKED
Unlock
Today vs. history

FRX looks overvalued.
But is it expensive by its own standards?

See how today’s valuation compares with FRX’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor FRX
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Current Price CA$14.78
Intrinsic Value Locked
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to FRX

Fundamental Analysis

What Fennec Pharmaceuticals Does

Biotechnology Health Care

Fennec Pharmaceuticals is a small specialty drug company focused on one main problem in cancer care: protecting children from hearing loss caused by the chemotherapy drug cisplatin. Its lead product, PEDMARK, is a prescription treatment used alongside cisplatin for patients with certain solid tumors. The company’s business is built around developing and commercializing this medicine for hospitals, cancer centers, and pediatric oncologists that treat these patients.

Headquarters
United States of America US
Employees
35
IPO date
Jun 5, 2001
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Fennec Pharmaceuticals Inc

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

Ownership

FENC Insider Trading
Buy and sell transactions by insiders

Continue FRX Research

Summary
FRX intrinsic value, competitors valuation, and company profile.
DCF Valuation
FRX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
FRX stock valuation using valuation multiples.
Wall St Estimates
FRX price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financial Statements
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
FRX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financial Statements
Discount Rate
Other Fennec Pharmaceuticals Inc listings:
NASDAQ • USD
FENC
 F • EUR
RV41
 SWB • EUR
RV41
Discover More
What is the Intrinsic Value of one FRX stock?

The intrinsic value for Fennec Pharmaceuticals Inc (FRX) under the Base Case is hidden CAD.

Is FRX stock undervalued or overvalued?

Compared with the current market price of 14.78 CAD, the stock appears hidden.

Back to Top
ALPHA SPREAD
Follow us
Join 362,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.